West Health

Press Releases

Filters

Nonprofit Generic Drug Company Co-Founded by Gary and Mary West Foundation Will Manufacture and Distribute Low-Cost Insulin

Posted

Civica Rx Announces Plan to Significantly Cut Insulin Prices for People with Diabetes San Diego, CA – March 3, 2022 – Civica Rx, the nation’s first not-for-profit generic pharmaceutical company co-founded by the Gary and Mary West Foundation in 2018, announced plans today to manufacture and distribute insulins at significantly lower prices than those currently on… Read more »

Drug Manufacturers Would Owe $150 Million If Build Back Better Were Law

Posted

New study quantifies BBB intended inflation penalties on 25 high-spend drugs for Medicare recipients WASHINGTON, DC – March 1, 2022 – Drug manufacturers would have paid over $150 million in inflation penalties during the first quarter of 2022 if the Build Back Better Act were a law, according to a new study from the nonprofit… Read more »

West Health Statement on CMS Aduhelm National Coverage Determination

Posted

January 12, 2022 WASHINGTON, DC – West Health Chief Executive Officer, Shelley Lyford, issued the following statement regarding the Centers for Medicare & Medicaid Services (CMS) draft national coverage determination for Aduhelm, the controversial Alzheimer’s treatment. West Health is a family of nonprofit, nonpartisan organizations dedicated to lowering healthcare costs to improve aging in America…. Read more »

New Tool to Address Quiet Epidemic of Malnutrition in Older Adults

Posted

SAN DIEGO, CA – JANUARY 10, 2022 — Research teams from West Health Institute, a nonpartisan, nonprofit organization dedicated to lowering healthcare costs and improving aging, and the University of North Carolina at Chapel Hill have developed a timely and easy-to-use new assessment program to diagnose and address a lesser-known epidemic among older Americans — malnutrition…. Read more »

Study Estimates New Framework for Medicare Negotiation Would Increase Federal Revenues by $100 Billion

Posted

Analysis of revisions to H.R. 3 estimates lower commercial market premiums and out-of-pocket costs WASHINGTON, DC – NOVEMBER 3, 2021 – As Congress revises legislation to reform prescription drug pricing, a new analysis conducted by the West Health Policy Center, and released by its Council for Informed Drug Spending Analysis (CIDSA), estimates that extending inflation penalties to the… Read more »

West Health Statement on Drug Pricing Deal in Build Back Better Act

Posted

November 2, 2021 WASHINGTON, DC – West Health President and Chief Executive Officer, Shelley Lyford, issued the following statement after a drug pricing reform agreement was reached as part of the Build Back Better legislation. West Health is a family of nonprofit, nonpartisan organizations dedicated to lowering healthcare costs to improve aging in America. “Today… Read more »

West Health Statement on Initial Build Back Better Framework

Posted

October 28, 2021 WASHINGTON, DC – West Health President and Chief Executive Officer, Shelley Lyford, issued the following statement in response to the Build Back Better framework unveiled today by President Biden. West Health is a family of nonprofit, nonpartisan organizations dedicated to lowering healthcare costs to improve aging in America. “If meaningful drug pricing… Read more »

9 in 10 Americans Want Dental Coverage as Part of Medicare

Posted

WASHINGTON, DC – Sept. 29, 2021 – More than 9 in 10 Americans believe dental coverage should be included in Medicare and 73% of Americans believe that high prescription drug prices are impeding the Medicare program’s ability to provide dental coverage for seniors, according to a new West Health and NORC AmeriSpeak survey. Over three-quarters… Read more »